99
December 2, 2025 | 16:32

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW

The most recent episodes of BrainStorm can be found below.
Thank you Genentech, Eisai, and Lundbeck for your support of BrainStorm.

33
February 7, 2023 | 13:55

George Vradenburg – The Future of Alzheimer’s Advocacy Part 2

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowing Alzheimer's disease. What

LISTEN NOW
32
January 17, 2023 | 16:23

George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowing Alzheimer's disease. What

LISTEN NOW
31
December 20, 2022 | 14:40

Ken Dychtwald - Breakthroughs at the Tipping Point

Rising longevity and the aging of boomers worldwide are radically altering both the demographic landscape and every aspect of our personal, social, financial, and political

LISTEN NOW
30
December 6, 2022 | 13:28

Dr. Larry Cahill – The Differences Between Female and Male Brains – part 2

Your brain controls and coordinates everything your body does from the movement of your fingers to your heart rate. It also plays a crucial role

LISTEN NOW
29
November 15, 2022 | 12:27

Dr. Larry Cahill - The Differences Between Female and Male Brains - part 1

Just as the bodies of men and women are different, so are their brains.
LISTEN NOW